ADVANCED MEDICAL TECHNOLOGY ASSN for ADVANCED MEDICAL TECHNOLOGY ASSN
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies - S. 1399/H.R. 6197 Issues related to S. 1717/H.R. 5343 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 2761/H.R. 5269 Lab Payments and Results Act Issues related to Medicare coverage of FDA's breakthrough devices Issues related to coverage of diabetes devices and supplies Issues related to Home Health Rule
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREG MICHAEL CRIST | — |
| NICK HALSTED | — |
| SARAH KILLEEN | — |
| JENNIFER TOMASELLO New | — |
| AMANDA WALSH | — |
| KIM ZIMMERMAN | — |
Health Issues HCR
Issues related to Privacy Legislation Issues related to remanufacturing and servicing medical devices Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 1539 - the Medical Device Electronic Labeling Act Issues related to National Defense Authorization Act Issues related to FDA regulation of diagnostic tests Issues related to the Countering CCP Act (S. 4939) Issues related to the Health Care Cybersecurity and Resiliency Act of 2025 (S. 3315)
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREG MICHAEL CRIST | — |
| NICK HALSTED | — |
| SARAH KILLEEN | — |
| JENNIFER TOMASELLO New | — |
| AMANDA WALSH | — |
| KIM ZIMMERMAN | — |
Budget/Appropriations BUD
Issues related to appropriations and user fee funding for the Food and Drug Administration
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREG MICHAEL CRIST | — |
| NICK HALSTED | — |
| SARAH KILLEEN | — |
| JENNIFER TOMASELLO New | — |
| AMANDA WALSH | — |
| KIM ZIMMERMAN | — |
Taxation/Internal Revenue Code TAX
Issues related to small business taxes
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREG MICHAEL CRIST | — |
| NICK HALSTED | — |
| SARAH KILLEEN | — |
| JENNIFER TOMASELLO New | — |
| AMANDA WALSH | — |
| KIM ZIMMERMAN | — |
Trade (domestic/foreign) TRD
Tariffs on medical devices United States-Mexico-Canada Agreement (USMCA) Global Trade and EU Tariffs
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREG MICHAEL CRIST | — |
| NICK HALSTED | — |
| SARAH KILLEEN | — |
| JENNIFER TOMASELLO New | — |
| AMANDA WALSH | — |
| KIM ZIMMERMAN | — |
Small Business SMB
Issues related to the reauthorization of the Small Business Innovation Research (SBIR) program. Issues related to small business taxes.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREG MICHAEL CRIST | — |
| NICK HALSTED | — |
| SARAH KILLEEN | — |
| JENNIFER TOMASELLO New | — |
| AMANDA WALSH | — |
| KIM ZIMMERMAN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.